Crinetics Pharmaceuticals (CRNX) EBT Margin (2017 - 2025)
Historic EBT Margin for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to 90972.73%.
- Crinetics Pharmaceuticals' EBT Margin changed N/A to 90972.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 27537.2%, marking a year-over-year decrease of 12604900.0%. This contributed to the annual value of 28625.51% for FY2024, which is 234131500.0% down from last year.
- Per Crinetics Pharmaceuticals' latest filing, its EBT Margin stood at 90972.73% for Q3 2025.
- In the past 5 years, Crinetics Pharmaceuticals' EBT Margin ranged from a high of 1074.23% in Q1 2022 and a low of 90972.73% during Q3 2025
- Over the past 5 years, Crinetics Pharmaceuticals' median EBT Margin value was 9641.23% (recorded in 2022), while the average stood at 16168.04%.
- Examining YoY changes over the last 5 years, Crinetics Pharmaceuticals' EBT Margin showed a top increase of 73389500bps in 2025 and a maximum decrease of -164058100bps in 2025.
- Crinetics Pharmaceuticals' EBT Margin (Quarter) stood at 2857.88% in 2021, then plummeted by -125bps to 6438.93% in 2022, then crashed by -153bps to 16302.89% in 2023, then fell by -14bps to 18556.89% in 2024, then tumbled by -390bps to 90972.73% in 2025.
- Its EBT Margin was 90972.73% in Q3 2025, compared to 11217.94% in Q2 2025 and 26750.97% in Q1 2025.